Accurate Signal-Source Localization in Brain Slices by Means of High- Density Microelectrode Arrays Received: 27 July 2018 Marie Engelene J
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Electrophysiological Phenotype Characterization of Human Ipsc-Derived Neuronal Cell Lines by Means of High-Density Microelectrode Arrays
bioRxiv preprint doi: https://doi.org/10.1101/2020.09.02.271403; this version posted September 2, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Electrophysiological Phenotype Characterization of Human iPSC-Derived Neuronal Cell Lines by Means of High-Density Microelectrode Arrays Silvia Ronchi1*, Alessio Paolo Buccino1, Gustavo Prack1, Sreedhar Saseendran Kumar1, Manuel Schröter1, Michele Fiscella1,2*† and Andreas Hierlemann1† 1Department of Biosystems Science and Engineering, ETH Zürich, Mattenstrasse 26, 4058 Basel, Switzerland 2MaxWell Biosystems AG, Albisriederstrasse 253, 8047 Zürich, Switzerland *Corresponding authors ([email protected], [email protected]) †Authors share senior authorship Keywords: induced pluripotent stem cells, high-density microelectrode arrays, electrophysiology Abstract Recent advances in the field of cellular reprogramming have opened a route to study the fundamental mechanisms underlying common neurological disorders. High-density microelectrode-arrays (HD-MEAs) provide unprecedented means to study neuronal physiology at different scales, ranging from network through single-neuron to subcellular features. In this work, we used HD-MEAs in vitro to characterize and compare human induced-pluripotent-stem-cell (iPSC)-derived dopaminergic and motor neurons, including isogenic neuronal lines modeling Parkinson’s disease and amyotrophic lateral sclerosis. We established reproducible electrophysiological network, single-cell and subcellular metrics, which were used for phenotype characterization and drug testing. Metrics such as burst shapes and axonal velocity enabled the distinction of healthy and diseased neurons. The HD-MEA metrics could also be used to detect the effects of dosing the drug retigabine to human motor neurons. -
A Comparison of the Performance and Application Differences Between Manual and Automated Patch-Clamp Techniques
Send Orders of Reprints at [email protected] Current Chemical Genomics, 2012, 6, 87-92 87 Open Access A Comparison of the Performance and Application Differences Between Manual and Automated Patch-Clamp Techniques Xiao Yajuan, Liang Xin and Li Zhiyuan* Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China Abstract: The patch clamp technique is commonly used in electrophysiological experiments and offers direct insight into ion channel properties through the characterization of ion channel activity. This technique can be used to elucidate the in- teraction between a drug and a specific ion channel at different conformational states to understand the ion channel modu- lators’ mechanisms. The patch clamp technique is regarded as a gold standard for ion channel research; however, it suffers from low throughput and high personnel costs. In the last decade, the development of several automated electrophysiology platforms has greatly increased the screen throughput of whole cell electrophysiological recordings. New advancements in the automated patch clamp systems have aimed to provide high data quality, high content, and high throughput. However, due to the limitations noted above, automated patch clamp systems are not capable of replacing manual patch clamp sys- tems in ion channel research. While automated patch clamp systems are useful for screening large amounts of compounds in cell lines that stably express high levels of ion channels, the manual patch clamp technique is still necessary for study- ing ion channel properties in some research areas and for specific cell types, including primary cells that have mixed cell types and differentiated cells that derive from induced pluripotent stem cells (iPSCs) or embryonic stem cells (ESCs). -
An Advanced Automated Patch Clamp Protocol Design to Investigate Drug – Ion Channel Binding Dynamics
bioRxiv preprint doi: https://doi.org/10.1101/2021.07.05.451189; this version posted July 6, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. An advanced automated patch clamp protocol design to investigate drug – ion channel binding dynamics. Peter Lukacs1, Krisztina Pesti2,3, Mátyás C. Földi1,2, Katalin Zboray1, Adam V. Toth1,2, Gábor Papp4, Arpad Mike1,2* 1Plant Protection Institute, Centre for Agricultural Research, Martonvásár, Hungary 2Department of Biochemistry, ELTE Eötvös Loránd University, Budapest, Hungary 3Semmelweis University, School of Ph.D. Studies, Budapest, Hungary 4Institute for Physics, ELTE Eötvös Loránd University, Budapest, Hungary. *Correspondence: Arpad Mike, [email protected] Keywords: automated patch-clamp, sodium channel inhibitor, binding kinetics, epilepsy, pain, neuromuscular disorders, lidocaine, riluzole Abstract Standard high throughput screening projects using automated patch-clamp instruments often fail to grasp essential details of the mechanism of action, such as binding/unbinding dynamics and modulation of gating. In this study, we aim to demonstrate that depth of analysis can be combined with acceptable throughput on such instruments. Using the microfluidics-based automated patch clamp, IonFlux Mercury, we developed a method for a rapid assessment of the mechanism of action of sodium channel inhibitors, including their state-dependent association and dissociation kinetics. The method is based on a complex voltage protocol, which is repeated at 1 Hz. Using this time resolution we could monitor the onset and offset of both channel block and modulation of gating upon drug perfusion and washout. -
Multiwell Microelectrode Array Technology for the Evaluation of Human Ipsc- Derived Neuron and Cardiomyocyte Development and Maturation
. Multiwell Microelectrode Array Technology for the Evaluation of Human iPSC- Derived Neuron and Cardiomyocyte Development and Maturation Clements, M.; Hayes, H.B.; Nicolini, A.M.; Arrowood, C.A; Clements, I.P.; Millard, D.C. Axion BioSystems, Atlanta, GA Multiwell MEA Technology MEA Assay with Neurons MEA Assay with Cardiomyocytes Why use microelectrode arrays? Neural Electrophysiology Phenotypes Cardiac Electrophysiology Phenotypes (a) (c) The flexibility and accessibility of induced pluripotent AxISTM control and analysis software provides The need for simple, reliable, and predictive pre-clinical assays for cardiac safety has motivated initiatives world-wide, stem cell (iPSC) technology has allowed complex human straightforward reporting of multiple measures on the including the Comprehensive in vitro Proarrhythmia Assay (CiPA) and Japan iPS Cardiac Safety Assessment (JiCSA). biology to be reproduced in vitro at previously maturity of the cell culture: The Maestro MEA platform enables assessment of functional in vitro cardiomyocyte activity with an easy-to-use benchtop unimaginable scales. Accurate characterization of stem system. The Maestro detects and records electrical signals from cells cultured directly onto an array of planar electrodes in each well of the MEA plate. Multiple electrodes in each well provide mechanistic electrophysiological data reflecting the cell-derived neurons and cardiomyocytes requires an • Functionality – Neurons within the population following important variables: assay to provide a functional phenotype. For these produce spontaneous action potentials. The mean electro-active cells, measurements of electrophysiological firing rate (MFR) counts action potentials over time to • Depolarization – Cardiomyocyte depolarization is detected by the amplitude of the field potential spike (AMP). activity across a networked population of cells provides a (b) quantify individual neuron functionality. -
Intraoperative Microelectrode Recordings in Substantia Nigra Pars Reticulata in Anesthetized Rats
fnins-14-00367 April 27, 2020 Time: 19:44 # 1 BRIEF RESEARCH REPORT published: 29 April 2020 doi: 10.3389/fnins.2020.00367 Intraoperative Microelectrode Recordings in Substantia Nigra Pars Reticulata in Anesthetized Rats Hanyan Li and George C. McConnell* Department of Biomedical Engineering, Stevens Institute of Technology, Hoboken, NJ, United States The Substantia Nigra pars reticulata (SNr) is a promising target for deep brain stimulation (DBS) to treat the gait and postural disturbances in Parkinson’s disease (PD). Positioning the DBS electrode within the SNr is critical for the development of preclinical models of SNr DBS to investigate underlying mechanisms. However, a complete characterization of intraoperative microelectrode recordings in the SNr to guide DBS electrode placement is lacking. In this study, we recorded extracellular single-unit activity in anesthetized rats at multiple locations in the medial SNr (mSNr), lateral SNr (lSNr), and the Ventral Tegmental Area (VTA). Immunohistochemistry and fluorescently dyed electrodes were used to map neural recordings to neuroanatomy. Neural recordings were analyzed in the time domain (i.e., firing rate, interspike interval (ISI) correlation, ISI variance, regularity, spike amplitude, signal-to-noise ratio, half-width, asymmetry, and latency) and the frequency domain (i.e., spectral power in frequency bands of interest). Spike amplitude Edited by: decreased and ISI correlation increased in the mSNr versus the lSNr. Spike amplitude, Reinhold Scherer, signal-to-noise ratio, and ISI correlation increased in the VTA versus the mSNr. ISI University of Essex, United Kingdom correlation increased in the VTA versus the lSNr. Spectral power in the VTA increased Reviewed by: versus: (1) the mSNr in the 20–30 Hz band and (2) the lSNr in the 20–40 Hz band. -
MATLAB-Based Automated Patch-Clamp System for Awake Behaving Mice
J Neurophysiol 114: 1331–1345, 2015. First published June 18, 2015; doi:10.1152/jn.00025.2015. Innovative Methodology MATLAB-based automated patch-clamp system for awake behaving mice Niraj S. Desai, Jennifer J. Siegel, William Taylor, Raymond A. Chitwood, and Daniel Johnston Center for Learning and Memory, Department of Neuroscience, The University of Texas at Austin, Austin, Texas Submitted 12 January 2015; accepted in final form 14 June 2015 Desai NS, Siegel JJ, Taylor W, Chitwood RA, Johnston D. fixation opens up the possibility of employing physiological MATLAB-based automated patch-clamp system for awake behaving and imaging methods that are extraordinarily difficult, al- mice. J Neurophysiol 114: 1331–1345, 2015. First published June 18, though not impossible (Lee et al. 2014; Ziv et al. 2013), in 2015; doi:10.1152/jn.00025.2015.—Automation has been an impor- tant part of biomedical research for decades, and the use of automated freely moving animals. and robotic systems is now standard for such tasks as DNA sequenc- Of special interest in this regard is whole cell patch-clamp ing, microfluidics, and high-throughput screening. Recently, Kodan- electrophysiology (Harvey et al. 2009; Margrie et al. 2002; daramaiah and colleagues (Nat Methods 9: 585–587, 2012) demon- Petersen and Crochet 2013; Polack et al. 2013). Since its strated, using anesthetized animals, the feasibility of automating blind introduction more than 30 years ago, the patch-clamp has patch-clamp recordings in vivo. Blind patch is a good target for assumed a central place in cell-type-specific neurobiology: it automation because it is a complex yet highly stereotyped process that allows for the measurement of suprathreshold and subthreshold revolves around analysis of a single signal (electrode impedance) and movement along a single axis. -
Efficient, Large-Scale Transfection Using the Maxcyte® STX™ System, Conven
® Rapid generation of cells for ion channel assays: efficient, large-scale transfection using the MaxCyte STX™ system, ® convenient cell culture using Corning HYPERFlask™ vessels, and robust target activity assayed by the Sophion QPatch. James Brady, Peer Heine, Rama Shivakumar, Angelia Viley, Madhusudan Peshwa, Karen Donato and Krista Steger. MaxCyte Inc., Gaithersburg, MD, USA. Mark Rothenberg. Corning Inc., Kennebunk, ME, USA. Hervør Lykke Olsen, Nikolaj Nielsen, Kristina Christensen, Jeffrey Webber and Morten Sunesen. Sophion Bioscience A/S , Ballerup, Denmark. Abstract Rapid and Scalable Approach to Generating Cells for Ion Channel Assays Robust Sodium Channel Activity in Transiently Transfected Cells Expansion in HYPERFlask Vessels and Transfection via Flow Electroporation High expression and strong currents detected by Sophion QPatch The MaxCyte® STX™ Scalable Transfection System uses a proprietary flow electroporation technology that can transfect up to 1E10 cells with target, reporter and A. Nav1.5 Activity 48 hrs post electroporation B. Sweep Plot protein expression plasmids, as well as other molecules, in less than 30 minutes. Sweep Plot Test Transfection Average current [DNA ] TTX block* Transfected cells can be assayed immediately or cryopreserved for future use. Here we condition efficiency level* demonstrate the use of the MaxCyte STX system in coordination with Corning’s® [mg/ml)] Temp. [°C] [%] [nA] [%] DisplayedDisplayed liquid liquidperiods periods HYPERFlask® Cell Culture Vessel to provide an efficient and economical -
Cross-Site and Cross-Platform Variability of Automated Patch Clamp Assessments of Drug Efects on Human Cardiac Currents in Recombinant Cells James Kramer1, Herbert M
www.nature.com/scientificreports There are amendments to this paper OPEN Cross-site and cross-platform variability of automated patch clamp assessments of drug efects on human cardiac currents in recombinant cells James Kramer1, Herbert M. Himmel2, Anders Lindqvist3, Sonja Stoelzle-Feix4, Khuram W. Chaudhary5, Dingzhou Li6, Georg Andrees Bohme7, Matthew Bridgland-Taylor8, Simon Hebeisen9, Jingsong Fan10, Muthukrishnan Renganathan11, John Imredy12, Edward S. A. Humphries13, Nina Brinkwirth4, Tim Strassmaier14, Atsushi Ohtsuki15, Timm Danker16, Carlos Vanoye17, Liudmila Polonchuk18, Bernard Fermini19, Jennifer Beck Pierson20* & Gary Gintant21 Automated patch clamp (APC) instruments enable efcient evaluation of electrophysiologic efects of drugs on human cardiac currents in heterologous expression systems. Diferences in experimental protocols, instruments, and dissimilar site procedures afect the variability of IC50 values characterizing drug block potency. This impacts the utility of APC platforms for assessing a drug’s cardiac safety margin. We determined variability of APC data from multiple sites that measured blocking potency of 12 blinded drugs (with diferent levels of proarrhythmic risk) against four human cardiac currents (hERG [IKr], hCav1.2 [L-Type ICa], peak hNav1.5, [Peak INa], late hNav1.5 [Late INa]) with recommended protocols (to minimize variance) using fve APC platforms across 17 sites. IC50 variability (25/75 percentiles) difered for drugs and currents (e.g., 10.4-fold for dofetilide block of hERG current and 4-fold for mexiletine block of hNav1.5 current). Within-platform variance predominated for 4 of 12 hERG blocking drugs and 4 of 6 hNav1.5 blocking drugs. hERG and hNav1.5 block. Bland-Altman plots depicted varying agreement across APC platforms. -
A Microelectrode Array (MEA) Integrated with Clustering Structures for Investigating in Vitro Neurodynamics in Confined Interconnected Sub-Populations of Neurons
Published in Sensors and Actuators B 114, issue 1, 530-541, 2006 1 which should be used for any reference to this work A microelectrode array (MEA) integrated with clustering structures for investigating in vitro neurodynamics in confined interconnected sub-populations of neurons L. Berdondini a,∗, M. Chiappalone b, P.D. van der Wal a, K. Imfeld a, N.F. de Rooij a, M. Koudelka-Hep a, M. Tedesco b, S. Martinoia b, J. van Pelt d, G. Le Masson c, A. Garenne c a Sensors, Actuators and Microsystems Laboratory, Institute of Microtechnology, University of Neuchatel,ˆ Jaquet-Droz 1, 2007 Neuchatel,ˆ Switzerland b Department of Biophysical and Electronic Engineering (DIBE), University of Genova, Via Opera Pia 11a, 16145 Genova, Italy c INSERM E358, University Bordeaux 2, 146 rue Leo´ Saignat, 33077 Bordeaux Cedex, France d Netherlands Institute for Brain Research (NIBR), Meibergdreef 33, 1105 AZ Amsterdam, The Netherlands Abstract Understanding how the information is coded in large neuronal networks is one of the major challenges for neuroscience. A possible approach to investigate the information processing capabilities of the neuronal ensembles is given by the use of dissociated neuronal cultures coupled to microelectrode arrays (MEAs). Here, we describe a new strategy, based on MEAs, for studying in vitro neuronal network dynamics in interconnected sub-populations of cortical neurons. The rationale is to sub-divide the neuronal network into communicating clusters while preserving a high degree of functional connectivity within each confined sub-population, i.e. to achieve a compromise between a completely random large neuronal population and a patterned network, such as currently used with conventional MEAs. -
Developing a Stable High-Throughput Assay Using Electroporation
Application Report Developing a stable high-throughput assay using electroporation transfected cells The Neon® Transfection System offers a gentle transfection method, allowing high- throughput pharmacological evaluation of the monomeric α1 glycine receptors on Qube. Summary • A stable Qube assay with high success rates (88%) using of the transfection and subsequently for pharmacological evalua- electroporation transfected cells tion of the glycine receptor. • Simultaneous testing of up to 16 cell preparations allows fast electroporation protocol optimization • Multi-hole technology enhances signals in cases of low Results and discussion transfection levels. In the following we: Introduction 1. Design an assay to evaluate electroporation efficiency Electroportation 2. Use this assay to optimize the electroporation protocol Electroporation is a technique allowing chemicals, drugs, or DNA to be introduced into the cell by applying an electrical field to the 3. Demonstrate a pharmacological assay on electroporation cells, thereby increasing the permeability of the cell membrane. transfected cells The Neon® Transfection System is a novel benchtop electropo- 1. Designing a glycine receptor assay to evaluate electropo- ration device that employs the pipette tip as an electroporation ration efficiency chamber to easily and efficiently transfect mammalian cells. Glycine receptor assay In this study, native HEK 293 cells were transfected with a plasmid To evaluate transfection efficiency (the fraction of cells expressing encoding the human glycine receptor α1 (hGlyRα1), to demon- the receptor) and experimental success rate (number of single-cell strate how a Qube can be used for: experiments passing through the experiment), a glycine recep- 1. optimization of electroporation transfection tor assay was developed. The assay consisted of 8 repetitions of glycine additions: 7 additions of 100 µM glycine (EC80 values 2. -
Deep Brain Stimulation Macroelectrodes Compared To
Deep brain stimulation macroelectrodes compared to multiple microelectrodes in rat hippocampus Sharanya Arcot Desai, Georgia Institute of Technology Claire-Anne Gutekunst, Emory University Steve Potter, Emory University Robert Gross, Emory University Journal Title: Frontiers in Neuroengineering Volume: Volume 7, Number JUN Publisher: Frontiers Media | 2014-06-12, Pages 16-16 Type of Work: Article | Final Publisher PDF Publisher DOI: 10.3389/fneng.2014.00016 Permanent URL: https://pid.emory.edu/ark:/25593/rsb7b Final published version: http://dx.doi.org/10.3389/fneng.2014.00016 Copyright information: © 2014 Arcot Desai, Gutekunst, Potter and Gross. This is an Open Access work distributed under the terms of the Creative Commons Attribution 3.0 Unported License (http://creativecommons.org/licenses/by/3.0/). Accessed September 25, 2021 7:22 PM EDT ORIGINAL RESEARCH ARTICLE published: 12 June 2014 doi: 10.3389/fneng.2014.00016 Deep brain stimulation macroelectrodes compared to multiple microelectrodes in rat hippocampus Sharanya Arcot Desai 1,2 , Claire-Anne Gutekunst 3 , Steve M. Potter 1,2 *† and Robert E. Gross 2,3 *† 1 Laboratory for Neuroengineering, Georgia Institute of Technology, Atlanta, GA, USA 2 The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA 3 Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, USA Edited by: Microelectrode arrays (wire diameter <50 μm) were compared to traditional macroelec- Laura Ballerini, University of Trieste, trodes for deep brain stimulation (DBS). Understanding the neuronal activation volume may Italy help solve some of the mysteries associated with DBS, e.g., its mechanisms of action. We Reviewed by: used c-fos immunohistochemistry to investigate neuronal activation in the rat hippocampus Luca Berdondini, Italian Institute of Technology, Italy caused by multi-micro- and macroelectrode stimulation. -
Automated Patch Clamping 18/1/06 09:26 Page 62
Automated patch clamping 18/1/06 09:26 Page 62 Ion Channel Screening AUTOMATED PATCH CLAMPING setting a new standard for early hERG By Dr John Comley Ion channel targets remain a top priority for many Pharma and Biotechs with most looking to increase their screening efforts in 2006.The impact of automated patch clamping (APC) on ion channel screening is now evident, particularly in early non-compliant hERG liability testing, where APC is rapidly becoming the new ‘gold standard’ technology. User feedback on the overall performance and patch success rates of the APC systems they have implemented for hERG has generally been very positive. However, it is still possible to discern small differences in opinion between APC users with a strong electrophysiology background and those without, particularly with respect to the level of accuracy required for an APC system compared to conventional patch clamping; the minimum seal resistance needed and preferred approach to the reuse of whole cell preparations. Overall a greater consensus exists today on the use of APC than a few years ago. It is now apparent that the deployment of APC instruments into primary screening will be limited until next generation APC platforms emerge. Most restrictive today is the high cost of APC consumables (eg patch plates); the lack of suitable high- throughput instruments able to adequately address both voltage-gated and ligand-gated channels; and measurement dependence on cell quality. Despite these limitations, the market for APC instruments is predicted to continue to grow, with deployment of APC technology widely adopted throughout drug discovery in pharma, biotech and academic research labs.